Levant Avital, Levy Einat, Argaman Miriam, Fleisher-Berkovich Sigal
Department of Clinical Pharmacology, Ben-Gurion University of the Negev, P.O.B 653 Beer-Sheva 84105, Israel.
Eur J Pharmacol. 2006 Sep 28;546(1-3):197-200. doi: 10.1016/j.ejphar.2006.06.074. Epub 2006 Jul 5.
The role of kinins, well known as peripheral inflammatory mediators, in the modulation of brain inflammation is unclear. The present data show that bradykinin, a bradykinin B(2) receptor agonist, enhanced both basal and lipopolysaccharide-induced prostaglandin E(2) synthesis in rat neonatal glial cells in culture. By contrast, Lys-des-Arg(9)-bradykinin, which is a kinin breakdown product and a selective bradykinin B(1) receptor agonist, attenuated both basal and lipopolysaccharide-induced production of prostaglandin E(2) in glia. These results suggest a feedback regulatory mechanism of kinins on glial cells, in which prostaglandin synthesis is initially enhanced by bradykinin (B(2)) and eventually blocked by the effect of the kinin breakdown product, acting on bradykinin B(1) receptors.
激肽作为外周炎症介质,其在调节脑内炎症中的作用尚不清楚。目前的数据表明,缓激肽(一种缓激肽B(2)受体激动剂)可增强培养的大鼠新生神经胶质细胞中基础状态下和脂多糖诱导的前列腺素E(2)合成。相比之下,Lys-去-Arg(9)-缓激肽是一种激肽降解产物和选择性缓激肽B(1)受体激动剂,可减弱神经胶质细胞中基础状态下和脂多糖诱导的前列腺素E(2)生成。这些结果提示了激肽对神经胶质细胞的一种反馈调节机制,其中前列腺素合成最初由缓激肽(B(2))增强,最终被激肽降解产物作用于缓激肽B(1)受体的效应所阻断。